Initial clinical trial and pharmacokinetics of ThymitaTM (AG337) by 10-day continuous infusion in patients with advanced solid tumors

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancer chemotherapy and pharmacology 1998, Vol.41 (2), p.167-170
Hauptverfasser:	CREAVEN, P. J, PENDYALA, L, MEROPOL, N. J, CLENDENINN, N. J, WU, E. Y, LOEWEN, G. M, PROEFROCK, A, JOHNSTON, A, DIXON, M
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic agents Biological and medical sciences Chemotherapy Medical sciences Pharmacology. Drug treatments
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	170
container_issue	2
container_start_page	167
container_title	Cancer chemotherapy and pharmacology
container_volume	41
creator	CREAVEN, P. J PENDYALA, L MEROPOL, N. J CLENDENINN, N. J WU, E. Y LOEWEN, G. M PROEFROCK, A JOHNSTON, A DIXON, M
description
format	Article
fullrecord	<record><control><sourceid>pascalfrancis</sourceid><recordid>TN_cdi_pascalfrancis_primary_2064666</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2064666</sourcerecordid><originalsourceid>FETCH-pascalfrancis_primary_20646663</originalsourceid><addsrcrecordid>eNqNjk1KxEAQhRtxwOh4h1q40EWgM91m3Ir4t5hd9kPZnZDSpDp0VZQcwHsbwQO4et-D78E7MUXl3a60d96dmsI678vbvfVn5lzk3VrrK-cK8_3KpIQDhIGYwgqafytyhKnHPGJIH8StUhBIHTT9MpJic4Dr-2fn9jfwtkBly4gLhMRKPKdZgLibhRKvABMqtawCX6Q9YPxEDm0ESQNF0HlMWbZm0-Eg7eVfXpirp8fm4aWcUNZPXV4nJMcp04h5Oe5s7eu6dv_UfgAhi1R5</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Initial clinical trial and pharmacokinetics of ThymitaTM (AG337) by 10-day continuous infusion in patients with advanced solid tumors</title><source>SpringerLink Journals</source><creator>CREAVEN, P. J ; PENDYALA, L ; MEROPOL, N. J ; CLENDENINN, N. J ; WU, E. Y ; LOEWEN, G. M ; PROEFROCK, A ; JOHNSTON, A ; DIXON, M</creator><creatorcontrib>CREAVEN, P. J ; PENDYALA, L ; MEROPOL, N. J ; CLENDENINN, N. J ; WU, E. Y ; LOEWEN, G. M ; PROEFROCK, A ; JOHNSTON, A ; DIXON, M</creatorcontrib><identifier>ISSN: 0344-5704</identifier><identifier>EISSN: 1432-0843</identifier><identifier>CODEN: CCPHDZ</identifier><language>eng</language><publisher>Berlin: Springer</publisher><subject>Antineoplastic agents ; Biological and medical sciences ; Chemotherapy ; Medical sciences ; Pharmacology. Drug treatments</subject><ispartof>Cancer chemotherapy and pharmacology, 1998, Vol.41 (2), p.167-170</ispartof><rights>1998 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,4010</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2064666$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>CREAVEN, P. J</creatorcontrib><creatorcontrib>PENDYALA, L</creatorcontrib><creatorcontrib>MEROPOL, N. J</creatorcontrib><creatorcontrib>CLENDENINN, N. J</creatorcontrib><creatorcontrib>WU, E. Y</creatorcontrib><creatorcontrib>LOEWEN, G. M</creatorcontrib><creatorcontrib>PROEFROCK, A</creatorcontrib><creatorcontrib>JOHNSTON, A</creatorcontrib><creatorcontrib>DIXON, M</creatorcontrib><title>Initial clinical trial and pharmacokinetics of ThymitaTM (AG337) by 10-day continuous infusion in patients with advanced solid tumors</title><title>Cancer chemotherapy and pharmacology</title><subject>Antineoplastic agents</subject><subject>Biological and medical sciences</subject><subject>Chemotherapy</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><issn>0344-5704</issn><issn>1432-0843</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><recordid>eNqNjk1KxEAQhRtxwOh4h1q40EWgM91m3Ir4t5hd9kPZnZDSpDp0VZQcwHsbwQO4et-D78E7MUXl3a60d96dmsI678vbvfVn5lzk3VrrK-cK8_3KpIQDhIGYwgqafytyhKnHPGJIH8StUhBIHTT9MpJic4Dr-2fn9jfwtkBly4gLhMRKPKdZgLibhRKvABMqtawCX6Q9YPxEDm0ESQNF0HlMWbZm0-Eg7eVfXpirp8fm4aWcUNZPXV4nJMcp04h5Oe5s7eu6dv_UfgAhi1R5</recordid><startdate>1998</startdate><enddate>1998</enddate><creator>CREAVEN, P. J</creator><creator>PENDYALA, L</creator><creator>MEROPOL, N. J</creator><creator>CLENDENINN, N. J</creator><creator>WU, E. Y</creator><creator>LOEWEN, G. M</creator><creator>PROEFROCK, A</creator><creator>JOHNSTON, A</creator><creator>DIXON, M</creator><general>Springer</general><scope>IQODW</scope></search><sort><creationdate>1998</creationdate><title>Initial clinical trial and pharmacokinetics of ThymitaTM (AG337) by 10-day continuous infusion in patients with advanced solid tumors</title><author>CREAVEN, P. J ; PENDYALA, L ; MEROPOL, N. J ; CLENDENINN, N. J ; WU, E. Y ; LOEWEN, G. M ; PROEFROCK, A ; JOHNSTON, A ; DIXON, M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pascalfrancis_primary_20646663</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Antineoplastic agents</topic><topic>Biological and medical sciences</topic><topic>Chemotherapy</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>CREAVEN, P. J</creatorcontrib><creatorcontrib>PENDYALA, L</creatorcontrib><creatorcontrib>MEROPOL, N. J</creatorcontrib><creatorcontrib>CLENDENINN, N. J</creatorcontrib><creatorcontrib>WU, E. Y</creatorcontrib><creatorcontrib>LOEWEN, G. M</creatorcontrib><creatorcontrib>PROEFROCK, A</creatorcontrib><creatorcontrib>JOHNSTON, A</creatorcontrib><creatorcontrib>DIXON, M</creatorcontrib><collection>Pascal-Francis</collection><jtitle>Cancer chemotherapy and pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>CREAVEN, P. J</au><au>PENDYALA, L</au><au>MEROPOL, N. J</au><au>CLENDENINN, N. J</au><au>WU, E. Y</au><au>LOEWEN, G. M</au><au>PROEFROCK, A</au><au>JOHNSTON, A</au><au>DIXON, M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Initial clinical trial and pharmacokinetics of ThymitaTM (AG337) by 10-day continuous infusion in patients with advanced solid tumors</atitle><jtitle>Cancer chemotherapy and pharmacology</jtitle><date>1998</date><risdate>1998</risdate><volume>41</volume><issue>2</issue><spage>167</spage><epage>170</epage><pages>167-170</pages><issn>0344-5704</issn><eissn>1432-0843</eissn><coden>CCPHDZ</coden><cop>Berlin</cop><pub>Springer</pub></addata></record>
fulltext	fulltext
identifier	ISSN: 0344-5704
ispartof	Cancer chemotherapy and pharmacology, 1998, Vol.41 (2), p.167-170
issn	0344-5704 1432-0843
language	eng
recordid	cdi_pascalfrancis_primary_2064666
source	SpringerLink Journals
subjects	Antineoplastic agents Biological and medical sciences Chemotherapy Medical sciences Pharmacology. Drug treatments
title	Initial clinical trial and pharmacokinetics of ThymitaTM (AG337) by 10-day continuous infusion in patients with advanced solid tumors
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T22%3A17%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pascalfrancis&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Initial%20clinical%20trial%20and%20pharmacokinetics%20of%20ThymitaTM%20(AG337)%20by%2010-day%20continuous%20infusion%20in%20patients%20with%20advanced%20solid%20tumors&rft.jtitle=Cancer%20chemotherapy%20and%20pharmacology&rft.au=CREAVEN,%20P.%20J&rft.date=1998&rft.volume=41&rft.issue=2&rft.spage=167&rft.epage=170&rft.pages=167-170&rft.issn=0344-5704&rft.eissn=1432-0843&rft.coden=CCPHDZ&rft_id=info:doi/&rft_dat=%3Cpascalfrancis%3E2064666%3C/pascalfrancis%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true